EVEROLIMUS Zentiva cpr 2.5 mg 30 pce
7680680000014
CH-68000
L01EG02
07.16.4.
Reimbursement limitations:
EVEROLIMUSZE
Traitement des patients atteints d'un carcinome à cellules rénales avancé après échec d'un traitement par …
1 / 3
google
Details
- Product number
- 6800001
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- everolimusum 2.5 mg, E 321, hypromellosum, lactosum 68 mg, lactosum monohydricum 6.25 mg, crospovidonum, magnesii stearas, pro compresso.
Articles (1)
Everolimus Zentiva 2.5 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
68.0 MG | Substance | HBESI |
|
(N/A)
|
6.25 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68000
- Drug name
- Everolimus Zentiva, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/05/2021
- Authorization expiration date
- 19/05/2026
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EVEROLIMUS Zentiva cpr 2.5 mg 30 pce
- Description (DE)
- EVEROLIMUS Zentiva Tabl 2.5 mg 30 Stk
- Market launch
- 20/05/2021
- Narcotic (BTM)
- No